Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IVA Colon Cancer AJCC v7”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Early research (Phase 1)Study completedNCT02041481
What this trial is testing

MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT03403634
What this trial is testing

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Metastatic Carcinoma in the LiverRecurrent Colorectal CarcinomaStage IV Colorectal Cancer AJCC v7+2 more
Roswell Park Cancer Institute 19
Not applicableStudy completedNCT02728804
What this trial is testing

S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

Who this might be right for
Stage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon Cancer+1 more
SWOG Cancer Research Network 380
Early research (Phase 1)Study completedNCT01383343
What this trial is testing

Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Rectal CarcinomaStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT03317119
What this trial is testing

Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colon CarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Carcinoma+22 more
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03087071
What this trial is testing

Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
EGFR NP_005219.2:p.S492RKRAS Gene MutationMAP2K1 Gene Mutation+5 more
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT03436563
What this trial is testing

M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability

Who this might be right for
Colon AdenocarcinomaHigh-Frequency Microsatellite InstabilityMetastatic Malignant Solid Neoplasm+8 more
M.D. Anderson Cancer Center 4
Not applicableEnded earlyNCT01280643
What this trial is testing

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03365882
What this trial is testing

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colon AdenocarcinomaERBB2 Gene AmplificationRectal Adenocarcinoma+16 more
SWOG Cancer Research Network 240
Testing effectiveness (Phase 2)Ended earlyNCT01365910
What this trial is testing

Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
Vanderbilt-Ingram Cancer Center 30
Large-scale testing (Phase 3)Ended earlyNCT01279681
What this trial is testing

Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Cognitive/Functional EffectsColorectal CancerNeurotoxicity
Alliance for Clinical Trials in Oncology 32
Not applicableWithdrawnNCT01941173
What this trial is testing

Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
City of Hope Medical Center
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00103311
What this trial is testing

SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIIA Colon Cancer+9 more
National Cancer Institute (NCI) 64
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Not applicableStudy completedNCT01243372
What this trial is testing

Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 1,142
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Early research (Phase 1)Ended earlyNCT02110953
What this trial is testing

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+8 more
Fox Chase Cancer Center 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT04294264
What this trial is testing

TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

Who this might be right for
Metastatic Colorectal CarcinomaRecurrent Colon CarcinomaRefractory Colorectal Carcinoma+3 more
Rutgers, The State University of New Jersey 50
Early research (Phase 1)Study completedNCT01254617
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more
National Cancer Institute (NCI) 24
Load More Results